Novo Nordisk Refocuses On GLP‑1 As AI Partner Advances Parkinson’s Bet
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Micha Breakstone, Ph.D., peers into a microscope. [Cellular Intelligence] Cellular Intelligence has acquired global rights to a clinical-stage…
Cellular Intelligence and Novo Nordisk to advance Parkinson’s cell therapy
Cellular Intelligence has acquired global rights to Novo Nordisk’s clinical‑stage cell therapy program for Parkinson’s disease, a fast-growing…